The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM

Stephen B. Edge; Carolyn C. Compton

doi:10.1245/s10434-010-0985-4

The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM

Stephen B. Edge, Carolyn C. Compton

CLAS-NS: Life Sciences, School of (SOLS)

Research output: Contribution to journal › Review article › peer-review

4871 Scopus citations

Abstract

The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.

Original language	English (US)
Pages (from-to)	1471-1474
Number of pages	4
Journal	Annals of Surgical Oncology
Volume	17
Issue number	6
DOIs	https://doi.org/10.1245/s10434-010-0985-4
State	Published - Jun 2010

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-010-0985-4

Fingerprint Dive into the research topics of 'The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM'. Together they form a unique fingerprint.

Cite this

@article{5dde046cf06f46e3b828f22c489f4bc1,

title = "The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM",

abstract = "The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.",

author = "Edge, {Stephen B.} and Compton, {Carolyn C.}",

year = "2010",

month = jun,

doi = "10.1245/s10434-010-0985-4",

language = "English (US)",

volume = "17",

pages = "1471--1474",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "6",

}

TY - JOUR

T1 - The american joint committee on cancer

T2 - The 7th edition of the AJCC cancer staging manual and the future of TNM

AU - Edge, Stephen B.

AU - Compton, Carolyn C.

PY - 2010/6

Y1 - 2010/6

N2 - The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.

AB - The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.

UR - http://www.scopus.com/inward/record.url?scp=77954818058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954818058&partnerID=8YFLogxK

U2 - 10.1245/s10434-010-0985-4

DO - 10.1245/s10434-010-0985-4

M3 - Review article

C2 - 20180029

AN - SCOPUS:77954818058

VL - 17

SP - 1471

EP - 1474

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 6

ER -